Showing results (11-20 of 113) with videos related to
Sort By:
Pageof 12
The Pediatric Infectious Disease Journal|March 9, 2013
Raltegravir in vitro effect on bilirubin bindingDiana F Clarke, Ronald J Wong, Larissa Wenning, et al.Expert Review of Clinical Pharmacology|October 18, 2017
Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerationsDiana F Clarke, Martina Penazzato, Edmund Capparelli, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2023
Brief Report: Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and PostpartumJeremiah D Momper, Mina Nikanjam, Brookie M Best, et al.HIV Clinical Trials|April 14, 2009
Zidovudine, lamivudine, and nelfinavir concentrations in amniotic fluid and maternal serumChantelle Bennetto-Hood, Yvonne J Bryson, Alice Stek, et al.The Pediatric Infectious Disease Journal|March 22, 2018
In Vitro Study on the Effect of Maraviroc or Dolutegravir on Bilirubin to Albumin BindingCynthia N Schreiner, Charles E Ahlfors, Ronald J Wong, et al.Expert Opinion on Drug Metabolism & Toxicology|March 4, 2020
Tenofovir alafenamide use in pregnant and lactating women living with HIVAhizechukwu C Eke, Kristina M Brooks, Rahel D Gebreyohannes, et al.Pediatric Quality & Safety|October 2, 2019
Improving Respiratory Support Practices to Reduce Chronic Lung Disease in Premature InfantsBernadette M Levesque, Laura Burnham, Natasha Cardoza, et al.Journal of Clinical Pharmacology|December 20, 2011
Developmental pharmacokinetic changes of Lamivudine in infants and childrenAdriana H Tremoulet, Mina Nikanjam, Tim R Cressey, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2019
Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110Diana F Clarke, Mark Mirochnick, Edward P Acosta, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1Tim R Cressey, Gonzague Jourdain, Marc J Lallemant, et al.Pageof 12